Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 5, 2026

Fabrication of Decellularized Spleen Matrix Derived from Rats
05:16

Fabrication of Decellularized Spleen Matrix Derived from Rats

Published on: February 9, 2024

Artificial and bioartificial liver support.

Travis J McKenzie1, Joseph B Lillegard, Scott L Nyberg

  • 1Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.

Seminars in Liver Disease
|May 3, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Surgical Clerkship Guide: A Practical Framework for Confidence and Competence.

Cureus·2026
Same author

Prenatal Closure of Myeloschisis vs Myelomeningocele: Insights From the fMMC Consortium Registry.

Neurosurgery·2026
Same author

Morphological characterization of a novel model of steatohepatitis in the <i>FAH</i><sup><i>-/-</i></sup> pig.

Veterinary pathology·2026
Same author

Living Paired Exchange Donation: Unlocking New Horizons in Kidney Transplantation.

Mayo Clinic proceedings·2025
Same author

Fetal Myelomeningocele Closure in the Setting of Maternal Body Mass Index 35 to 40.

Neurosurgery·2025
Same author

Effect of very preterm delivery on outcomes following in utero spina bifida repair.

Pregnancy (Hoboken, N.J.)·2025
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
Same journal

Practical Guide to Best Practices in Alcohol-Associated Liver Disease.

Seminars in liver disease·2026
See all related articles

Acute liver failure (ALF) demands better treatments. While liver support devices show promise, further trials are needed to confirm their effectiveness in improving patient survival rates.

Area of Science:

  • Hepatology
  • Biomedical Engineering
  • Regenerative Medicine

Background:

  • Acute liver failure (ALF) presents a significant global health challenge with poor patient outcomes.
  • Liver transplantation remains the sole definitive treatment for ALF, but donor organ scarcity limits its application.
  • Liver support technologies aim to bridge the gap until native liver recovery or transplantation becomes possible.

Purpose of the Study:

  • To review the current landscape of artificial and bioartificial liver support devices for ALF.
  • To assess the clinical progress and challenges associated with these emerging technologies.
  • To highlight the need for further research and randomized controlled trials.

Main Methods:

  • Review of existing literature on artificial and bioartificial liver support systems.

More Related Videos

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat
13:27

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat

Published on: October 6, 2018

Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion
08:54

Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion

Published on: April 27, 2015

Related Experiment Videos

Last Updated: Jul 5, 2026

Fabrication of Decellularized Spleen Matrix Derived from Rats
05:16

Fabrication of Decellularized Spleen Matrix Derived from Rats

Published on: February 9, 2024

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat
13:27

A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat

Published on: October 6, 2018

Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion
08:54

Functional Human Liver Preservation and Recovery by Means of Subnormothermic Machine Perfusion

Published on: April 27, 2015

  • Analysis of current clinical testing and technological advancements.
  • Discussion of the limitations and future directions for ALF treatment modalities.

    • Main Results:

    • Two primary categories of liver support devices are under investigation: purely mechanical systems (e.g., albumin dialysis) and bioartificial devices incorporating cellular components.
    • No single liver support system has yet demonstrated a reproducible improvement in patient mortality rates.
    • Ongoing technological advancements and improved cell acquisition techniques are paving the way for future innovations.

    Conclusions:

    • Artificial and bioartificial liver support devices represent promising therapeutic avenues for ALF.
    • Further rigorous randomized controlled trials are essential to establish the efficacy and safety of these devices.
    • The ultimate role of these technologies in improving ALF patient survival requires continued investigation and validation.